$LRCX

LRCX Maintained by UBS -- Price Target Lowered to $425

UBS maintained a 'Buy' rating on Lam Research (LRCX) but lowered its price target from $435 to $425. GuruFocus estimates LRCX as 94.5% overvalued, with a GF Value of $150.71 vs. current price of $293.18. Insiders sold $68.3M in shares over three months. The company's GF Score is 85/100, reflecting strong profitability and growth but poor valuation.

Original reporting
Published Sep 1, 2026, 3:40 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Sep 1, 2026, 6:15 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$LRCX
Neutral
medium confidence
Mentioned
$LRCX
Relevance
4/10
alphai data visualization · based on gurufocus.com
Decision brief

The 30-second read

$LRCXNeutralLow
01

Why it matters

Analyst target reduction reflects market softness; investors may adjust positions.

02

Market read

Minor price‑target adjustment with limited immediate trading impact.

03

What to watch

Insider selling of $68 M could signal additional downside pressure.

Relevance 4/10Novelty 4/10Timing: post‑Oct 2023 rating update

Background

Lam Research is a leading wafer‑fab equipment supplier with exposure to memory chip demand.

Company-level read

Ticker impact

$LRCXNeutralMedium confidence
Context

UBS maintained a Buy rating but lowered the price target to $425, indicating a more cautious outlook.

Expected impact

Potential slight downside as investors reassess valuation.

Evidence & confidence

The target reduction is modest (2.3%) and follows existing overvaluation concerns; impact likely limited.

Market effects

May reinforce broader caution on semiconductor equipment makers.

Limited to U.S. and global semiconductor investors.

Low; affects only Lam Research and peers.

Counterpoint

Some investors may view the price‑target cut as an entry point given strong fundamentals.

Key entities

  • Lam Research Corp

    Semiconductor equipment manufacturer (ticker LRCX).

  • UBS

    Maintained Buy rating, lowered price target.

Related articles

$LRCXMed

The Memory Crunch Is Bigger Than Expected. 1 Top Stock to Buy on the Dip (Hint: Not Micron or Sandisk)

Lam Research (LRCX) is benefiting from a memory chip supply crunch, with revenue up 26% and earnings up 39% in fiscal 2026. The company expects 52% revenue growth and 71% earnings growth in the current quarter. Deloitte projects memory manufacturer capex to rise significantly, favoring Lam's semiconductor equipment sales. Analysts forecast 62% EPS growth for fiscal 2027, with potential for further upside.

$LRCXMedAI 8/10

Ministry approves Lam Research's NT$9.8 billion Taiwan investment

Taiwan's Ministry of Economic Affairs approved Lam Research's NT$9.835 billion (US$310 million) investment in its Taiwan subsidiary for semiconductor equipment R&D. Other approved investments include Zhen Ding Technology's NT$3 billion in Boardtek Electronics, Nuvoton's 15 billion yen in its Japan unit, and Foxconn's US$57.01 million in Mitsubishi Fuso Bus.